BeStock  
Stocks › Biotechnology › ROIV

Roivant Sciences ROIV

US equityMarket cap rank #706Biotechnology
$38.66 −$0.31 (-0.78%)
Market closed · Nov 22, 5:30 am ET · Last extended-hours $38.68 +0.06%
Open$38.86
Prev close$38.96
Day range$38.46 – $39.51
Volume3.97M
Market cap$28.01B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±5.3%last 16 reports
Closed higher11 of 1669% of the time
Best reaction+22.1%
Worst reaction-3.2%

Stock move on the day after each report

-0.6%2024/Q3-3.2%2024/Q4+6.7%2025/Q1-1.4%2025/Q2-0.9%2025/Q3+6.4%2025/Q4-2.8%2026/Q1+2.7%2026/Q2+22.1%2026/Q3+14.9%2026/Q4+1.5%2027/Q1+4.6%2027/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2027/Q29 Nov 2026Pre Market±11.7%+4.60%Within range
2027/Q16 Aug 2026Pre Market±10.8%+1.50%Within range
2026/Q420 May 2026Pre Market±10.9%+14.89%Bigger than priced
2026/Q36 Feb 2026Pre Market±5.7%+22.14%Bigger than priced
2026/Q210 Nov 2025None±8.1%+2.67%Within range
2026/Q111 Aug 2025Pre Market±9.7%-2.79%Within range
2025/Q429 May 2025None±9.3%+6.40%Within range
2025/Q310 Feb 2025None±8.9%-0.92%Within range
2025/Q212 Nov 2024Pre Market±6.8%-1.44%Within range
2025/Q18 Aug 2024Pre Market±15.0%+6.69%Within range
2024/Q430 May 2024Pre Market±10.3%-3.17%Within range
2024/Q313 Feb 2024Pre Market±9.1%-0.64%Within range
2024/Q114 Aug 2023Pre Market±17.1%+1.21%Within range
2023/Q428 Jun 2023Pre Market±21.0%+11.27%Within range
2023/Q313 Feb 2023Pre Market±23.9%+1.76%Within range
2023/Q214 Nov 2022None±23.9%+2.52%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q2, ended Sep 2026

Revenue$35.12M+2,135.6% YoY
Operating profit-$268.05M+12.5% YoY
Net profit-$137.21M+17.4% YoY
Diluted EPS-$0.27-58.8% YoY
Free cash flow$594.21M+407.1% YoY
Operating cash flow$594.42M

Revenue, last 8 quarters

$9.0MDec '24$7.6MMar '25$2.2MJun '25$1.6MSep '25$2.0MDec '25$2.5MMar '26$1.4MJun '26$35.1MSep '26

Net profit, last 8 quarters

$118.1MDec '24$-252.4MMar '25$-273.9MJun '25$-166.0MSep '25$-313.7MDec '25$355.7MMar '26$-290.6MJun '26$-137.2MSep '26

Profitability & balance sheet

Gross margin88.7%
Operating margin-3,234.0%
Net margin-838.2%
Return on equity-8.2%
Return on assets-6.9%
Return on invested capital-10.9%
Current ratio15.56
Liabilities / assets100.0%
Total debt$92.79M

Discussion

No comments yet — be the first to weigh in on ROIV.

Sign in to join the discussion.

Scroll to Top